MREO short interest
Mereo BioPharma Group plc · Healthcare · Biotechnology · settlement date 2026-09-30
| Shares short | 2,678,406 |
|---|---|
| Change vs prior report | -397,521 (-12.9%) |
| Change over six months | -75.4% |
| Days to cover | 1.25 (sector: 3.78) |
| Average daily volume | 2,142,878 |
| Rank in Healthcare | #756 of 922 by days to cover |
MREO short interest, last 12 months
| Settlement | Shares short | Change | Days to cover | Avg daily volume |
|---|---|---|---|---|
| 2026-09-30 | 2,678,406 | -12.9% | 1.25 | 2,142,878 |
| 2026-09-15 | 3,075,927 | -18.3% | 1.96 | 1,566,549 |
| 2026-08-31 | 3,764,977 | -12.8% | 3.42 | 1,101,379 |
| 2026-08-14 | 4,316,265 | +26.4% | 1.00 | 17,702,033 |
| 2026-07-31 | 3,413,324 | -3.5% | 3.36 | 1,015,887 |
| 2026-07-15 | 3,535,905 | -39.9% | 3.23 | 1,096,197 |
| 2026-06-30 | 5,883,564 | +10.0% | 3.18 | 1,851,783 |
| 2026-06-15 | 5,347,606 | -34.5% | 1.55 | 3,448,314 |
| 2026-05-29 | 8,160,044 | +43.6% | 1.00 | 11,050,210 |
| 2026-05-15 | 5,683,903 | -12.7% | 3.14 | 1,812,698 |
| 2026-04-30 | 6,508,278 | -21.3% | 4.42 | 1,473,737 |
| 2026-04-15 | 8,267,481 | -24.2% | 4.84 | 1,709,361 |
| 2026-03-31 | 10,907,448 | -3.1% | 7.70 | 1,416,670 |
| 2026-03-13 | 11,262,015 | -18.2% | 7.85 | 1,433,891 |
| 2026-02-27 | 13,764,845 | -2.3% | 5.38 | 2,560,589 |
| 2026-02-13 | 14,093,360 | +8.1% | 3.92 | 3,595,320 |
| 2026-01-30 | 13,042,775 | +32.9% | 1.50 | 8,676,296 |
| 2026-01-15 | 9,814,341 | -6.7% | 1.00 | 36,014,698 |
| 2025-12-31 | 10,517,934 | +7.5% | 1.00 | 34,324,222 |
| 2025-12-15 | 9,785,445 | +6.3% | 3.35 | 2,921,301 |
| 2025-11-28 | 9,207,930 | -0.5% | 7.22 | 1,274,555 |
| 2025-11-14 | 9,249,501 | -8.6% | 6.44 | 1,437,236 |
| 2025-10-31 | 10,121,542 | -9.3% | 6.12 | 1,653,871 |
| 2025-10-15 | 11,162,287 | -3.5% | 7.55 | 1,478,268 |
| 2025-09-30 | 11,561,612 | +4.7% | 10.69 | 1,081,428 |
import finzdata as yf
yf.Ticker("MREO").short_interest # every report since 2017
yf.Client().short_interest(["MREO"], start="2018-01-01")Healthcare short interest · MREO price history · Who owns MREO · All short interest